Hemagen Diagnostics (Hemagen Diagnostics) EPS (Basic) : $-0.06 (TTM As of Sep. 2012)

View and export this data going back to . Start your Free Trial

What is Hemagen Diagnostics EPS (Basic)?

Hemagen Diagnostics's basic earnings per share (Basic EPS) for the three months ended in Sep. 2012 was $-0.01. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2012 was $-0.06.

Hemagen Diagnostics's EPS (Diluted) for the three months ended in Sep. 2012 was $-0.01. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2012 was $-0.06.

Hemagen Diagnostics's EPS without NRI for the three months ended in Sep. 2012 was $-0.01. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2012 was -0.06.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Hemagen Diagnostics EPS (Basic) Historical Data

The historical data trend for Hemagen Diagnostics's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hemagen Diagnostics EPS (Basic) Chart

Hemagen Diagnostics Annual Data

Trend

Sep03

Sep04

Sep05

Sep06

Sep07

Sep08

Sep09

Sep10

Sep11

Sep12

EPS (Basic)

Get a 7-Day Free Trial

0.03

-0.05

-0.01

-0.06

Hemagen Diagnostics Quarterly Data
	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12
EPS (Basic)	Get a 7-Day Free Trial															-0.02	-0.02	-0.02	-0.01	-0.01

Hemagen Diagnostics EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Hemagen Diagnostics's Basic EPS for the fiscal year that ended in Sep. 2012 is calculated as

Basic EPS (A: Sep. 2012 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-0.907	-	0)	/	15.496
	=	-0.06

Hemagen Diagnostics's Basic EPS for the quarter that ended in Sep. 2012 is calculated as

Basic EPS (Q: Sep. 2012 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-0.163	-	0)	/	15.500
	=	-0.01

EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2012 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.06

Hemagen Diagnostics (OTCPK:HMGN) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Hemagen Diagnostics EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Hemagen Diagnostics's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Hemagen Diagnostics (Hemagen Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hemagen Diagnostics Inc (OTCPK:HMGN) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

9033 Red Branch Road, Columbia, MD, USA, 21045

Website

http://www.hemagen.com

Hemagen Diagnostics Inc is a biotechnology company. It develops, manufactures and markets Food and Drug Administration cleared proprietary medical diagnostic test kits and components. The company's Virgo line of Immunoassays are used to aid in the diagnosis of autoimmune and infectious diseases and acute-phase proteins. The assays utilize multiple technologies including ELISA, immunofluorescence (IFA) and hemagglutination (HA). Its products include ANA Screen ELISA 96 Test System, Rubella IgG ELISA 96 Test System, AMA IFA 48 Test System and others.

Executives

Howard F Curd

director

Hemagen Diagnostics (Hemagen Diagnostics) Headlines

No Headlines